Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

2.

Tuberous sclerosis gene products in proliferation control.

Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M.

Mutat Res. 2001 Jul;488(3):233-9. Review.

PMID:
11397651
3.

Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.

Kwiatkowski DJ.

Cancer Biol Ther. 2003 Sep-Oct;2(5):471-6. Review.

PMID:
14614311
4.

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Kwiatkowski DJ, Manning BD.

Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. Review.

PMID:
16244323
5.

Insulin signaling: lessons from the Drosophila tuberous sclerosis complex, a tumor suppressor.

Montagne J, Radimerski T, Thomas G.

Sci STKE. 2001 Oct 23;2001(105):pe36. Review.

PMID:
11675514
6.

The cell cycle and tuberous sclerosis.

Hengstschläger M, Rosner M.

Prog Cell Cycle Res. 2003;5:43-8. Review.

PMID:
14593699
7.

Tuberous sclerosis as an underlying basis for infantile spasm.

Yeung RS.

Int Rev Neurobiol. 2002;49:315-32. Review.

PMID:
12040899
8.

The tuberous sclerosis complex genes in tumor development.

Mak BC, Yeung RS.

Cancer Invest. 2004;22(4):588-603. Review.

PMID:
15565817
9.

Tuberous sclerosis: from tubers to mTOR.

Kwiatkowski DJ.

Ann Hum Genet. 2003 Jan;67(Pt 1):87-96. Review.

PMID:
12556239
10.

The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.

Nobukini T, Thomas G.

Novartis Found Symp. 2004;262:148-54; discussion 154-9, 265-8. Review.

PMID:
15562827
11.

The tuberous sclerosis complex (TSC) pathway and mechanism of size control.

Potter CJ, Pedraza LG, Huang H, Xu T.

Biochem Soc Trans. 2003 Jun;31(Pt 3):584-6. Review.

PMID:
12773160
12.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.

Astrinidis A, Henske EP.

Oncogene. 2005 Nov 14;24(50):7475-81. Review.

PMID:
16288294
13.

Tuberous sclerosis complex: genetics to pathogenesis.

Narayanan V.

Pediatr Neurol. 2003 Nov;29(5):404-9. Review.

PMID:
14684235
14.

Molecular genetic advances in tuberous sclerosis.

Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ.

Hum Genet. 2000 Aug;107(2):97-114. Review.

PMID:
11030407
15.

[From gene to disease; TSC1 and TSC2 genes and tuberous sclerosis complex].

Verhoef S, Lindhout D, Halley DJ, van den Ouweland AM.

Ned Tijdschr Geneeskd. 2001 Oct 6;145(40):1928-30. Review. Dutch.

PMID:
11675974
16.

Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.

Henske EP.

Pediatr Nephrol. 2005 Jul;20(7):854-7. Epub 2005 Apr 26. Review.

PMID:
15856327
17.

TSC1 and TSC2 gene mutations in human kidney tumors.

Kajino K, Hino O.

Contrib Nephrol. 1999;128:45-50. Review. No abstract available.

PMID:
10597376
18.

Hamartin and tuberin modulate gene transcription via beta-catenin.

Jozwiak J, Wlodarski P.

J Neurooncol. 2006 Sep;79(3):229-34. Epub 2006 Mar 22. Review.

PMID:
16552619
19.

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours.

Knowles MA, Hornigold N, Pitt E.

Biochem Soc Trans. 2003 Jun;31(Pt 3):597-602. Review.

PMID:
12773163
20.

Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.

Nellist M, Goedbloed MA, Halley DJ.

Biochem Soc Trans. 2003 Jun;31(Pt 3):587-91. Review.

PMID:
12773161

Supplemental Content

Support Center